Alkaloids and Saponins as Cytochrome P450 Inhibitors from Blue Cohosh (Caulophyllum thalictroides) in an in vitro Assay

Abstract

Blue cohosh, Caulophyllum thalictroides (L.) Michx. is a popular herb, roots and rhizomes of which have been extensively used for women’s health. Alkaloids and saponins are considered to be responsible for its pharmacological effects. In this investigation the methanolic extract of the roots of blue cohosh, the alkaloidal fraction and isolated constituents were evaluated for their inhibition of major drug metabolizing cytochrome P450 (CYP450) enzymes. The methanolic extract did not show any effect but the alkaloidal fraction showed a strong inhibition of CYP 2C19, 3A4, 2D6, and 1A2 (> 80 % inhibition at 100 μg/mL) with IC₅₀ values in the range of 2 – 20 μg/mL. Among the isolated alkaloids, a piperidine-type alkaloid (caulophyllumine B) and three lysine-derived alkaloids (O-acetlybaptifolin, anagyrine, and lupanine) inhibited these enzymes to various extents (IC₅₀ : 2.5 – 50 μM). N-Methylcytisine weakly inhibited CYP3A4 only (32 % inhibition at 100 μM). An equimolar mixture of alkaloids exhibited a more pronounced inhibitory effect on all four enzymes as compared to the isolated alkaloids. Among the saponins, caulosides C and D inhibited CYP3A4 at the highest test concentration of 100 μM (43 % and 35 % inhibition, respectively). Other enzymes were not affected. This in vitro study indicates that dietary supplements containing blue cohosh may pose a risk of drug-drug interactions if taken with other drugs or herbs, metabolism of which involves CYP450 enzymes.

Abbreviations

CYP450:Cytochrome P450

blue cohosh - Caulophyllum thalictroides - Berberidaceae - oleanolic acid saponins - alkaloids - cytochrome P450

References

• 1 Dugoua J J, Perri D, Seely D, Mills E, Koren G. Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation.  Can J Clin Pharmacol. 2008;  15 66-73
• 2 Kennelly E J, Flynn T J, Mazzola E P, Roach J A, McCloud T G, Danford D E. Detecting potential teratogenic alkaloids from blue cohosh rhizomes using an in vitro rat embryo culture.  J Nat Prod. 1999;  62 1385-9
• 3 Schmeller S, Sauerwein M, Sporer F, Wink M, Muller W E. Binding of quinolizidine alkaloids to nicotinic and muscarinic acetylcholine receptors.  J Nat Prod. 1994;  57 1316-9
• 4 Tyler V E. Blue cohosh. Binghamton; The Haworth Herbal Press 1999: 55-6
• 5 Coon N. Familiar medicinal plants. Emmaus; Rodale Press 1979: 81
• 6 Butterweck V, Derendorf H, Gaus W, Nahrstedt A, Schulz V, Unger M. Pharmacokinetic herb-drug interactions: Are preventive screenings necessary and appropriate?.  Planta Med. 2004;  70 784-91
• 7 Food and Drug Administration. Drug interaction studies: study design data analysis, and implications for dosing and labelling. CDER, U.S Department of Health and Human Services, CBER, FDA 2004
• 8 Liu Y, Yang L. Early metabolism evaluation making Traditional Chinese Medicine effective and safe therapeutics.  J Zhejiang Univ Sci B. 2006;  7 99-106
• 9 Barone G W, Gurley B J, Ketel B L, Lightfoot M L, Abul-Ezz S R. Drug interactions between St. John’s wort and cyclosporine.  Ann Pharmacother. 2000;  34 239-55
• 10 Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract.  New Engl J Med. 1997;  336 1108
• 11 Usia T, Iwata H, Hiratsuka A, Watabe T, Kadota S, Tezuka Y. CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants.  . 2006;  3 67-73.
• 12 Ali Z, Khan I A. Alkaloids and saponins from blue cohosh.  Phytochemistry. 2008;  69 1037-42
• 13 Crespi C L, Miller V P, Penman B W. Microtiter plate assays for inhibition of human drug-metabolizing cytochromes P450.  Anal Biochem. 1997;  248 188-90